で組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C42H74D7NO3
CAS番号:
分子量:
655.14
MDL number:
UNSPSC Code:
12352100
NACRES:
NA.25
Assay:
>99% (TLC)
Form:
powder
製品名
C24:1 Ceramide-d7 (d18:1-d7/24:1(15Z)), Avanti Research™ - A Croda Brand 860679P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (860679P-1mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860679P
shipped in
dry ice
storage temp.
−20°C
SMILES string
OC[C@]([H])(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)[C@@](O)([H])/C=C/CCCCCCCCCCC(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H]
InChI key
VJSBNBBOSZJDKB-PVDQZAGSSA-N
General description
C24:1 Ceramide (d18:1/24:1) is a synthetic ceramide derived from sphingosine with nervonic acid (a monounsaturated analog of lignoceric acid (24:0)). C24:1 Ceramide-d7 (d18:1-d7/24:1(15Z)) is a deuterated derivative of C24:1 Ceramide (d18:1/24:1).
Application
C24:1 Ceramide-d7 (d18:1-d7/24:1(15Z)) has been used as a standard in liquid chromatography–mass spectrometry (LC-MS) for quantitative analysis of C24:1 ceramide in skeletal muscle. It has also been used as a standard to measure C40-C44 ceramides in zebrafish brain and human embryonic kidney cell line (HEK293) by thermo q-exactive plus quadrupole-orbitrap mass spectrometery.
Biochem/physiol Actions
Monitoring the levels of the ceramides (Cer) d18:1/16:0, Cer d18:1/18:0, Cer d18:1/24:0, and Cer d18:1/24:1 and ratios in human plasma aids the prognosis of fatal outcome of coronary artery disease. C24:1 Ceramide (d18:1/24:1) in a stable isotope form is suitable for a newly described validated liquid chromatography-tandem mass spectrometry methodology for their clinical-scaled measurement.
Packaging
5 mL Amber Glass Screw Cap Vial (860679P-1mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
保管分類
11 - Combustible Solids
flash_point_f
No data available
flash_point_c
No data available